MorphiSec
The company provides an endpoint security platform powered by patented Automated Moving Target Defense (AMTD) technology to preemptively stop ransomware and advanced memory-based threats. Its suite includes adaptive exposure management, infiltration protection, and incident recovery tools designed to supplement existing EDR and NGAV solutions. The platform serves lean IT teams and large enterprises across sectors such as manufacturing, finance, healthcare, and education.
Cybersecurity
Finance
Manufacturing
Healthcare
Education
Technology
Funding summary
- Total raised
- €43.8M
- Funding rounds
- 4
Investors in MorphiSec
Investors on record for MorphiSec. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like MorphiSec?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors